SMC OK's atazanavir, rabeprazole, valsartan/hydrochlorothiazide . . . News item 30 January 2013 Pages: 3 - 3
Is the use of the `transfer to utility' method valid in economic analyses? News item 30 January 2013 Pages: 4 - 4
Injudicious antibacterial use in France, particularly among children Clinical study 30 January 2013 Pages: 5 - 5
Use of folic acid increases among US women of childbearing age Clinical study 30 January 2013 Pages: 5 - 5
News from the 13th International Conference on Pharmaceutical Medicine Meeting report 30 January 2013 Pages: 6 - 6
Anti-D-Rh0-immunoglobulin: routine antenatal use worth it? Clinical study 30 January 2013 Pages: 7 - 7
Donepezil cost saving to society in moderate-to-severe AD Clinical study 30 January 2013 Pages: 7 - 7
US physicians heed warnings over paediatric antidepressant use Media release 30 January 2013 Pages: 7 - 7
OTC drugs often used to control Australian children's behaviour Clinical study 30 January 2013 Pages: 8 - 8
Hip protectors offer US elderly good value hip fracture prevention Clinical study 30 January 2013 Pages: 9 - 9
Cognitive behavioural therapy better value than SSRIs in children Clinical study 30 January 2013 Pages: 10 - 10
CYP2C9-based warfarin therapy better value than standard care Clinical study 30 January 2013 Pages: 10 - 10
New use of antipsychotics rising among US children, adolescents News item 30 January 2013 Pages: 10 - 10
Cognitive behavioural therapy good value for GAD, panic disorder Clinical study 30 January 2013 Pages: 11 - 11
Dexamethasone of economic benefit among children with mild croup Clinical study 30 January 2013 Pages: 11 - 11
Decline in use slow after safety warnings for cisapride, troglitazone Clinical study 30 January 2013 Pages: 12 - 12
Hospice care for dying elderly not a drain on resources Clinical study 30 January 2013 Pages: 12 - 12
Duloxetine reduces incontinence frequency, improves QOL Clinical study 30 January 2013 Pages: 14 - 14
Etanercept, efalizumab repair QOL in chronic plaque psoriasis Meeting report 30 January 2013 Pages: 14 - 14
Eli Lilly scores NCQA certification for five DM programmes Media release 30 January 2013 Pages: 15 - 15
Neuroprotectant market set to reach $US11.5 billion by 2010 Media release 30 January 2013 Pages: 15 - 15
Pricing pressure for fluconazole, Ukraine strikes HIV/AIDS deal News item 30 January 2013 Pages: 15 - 15
UK NHS spending rise not paired with increased healthcare activity News item 30 January 2013 Pages: 15 - 15